Navigation Links
In the lab, scientists coax E. coli to resist radiation damage
Date:3/14/2014

MADISON, Wis. Capitalizing on the ability of an organism to evolve in response to punishment from a hostile environment, scientists have coaxed the model bacterium Escherichia coli to dramatically resist ionizing radiation and, in the process, reveal the genetic mechanisms that make the feat possible.

The study, published in the online journal eLife, provides evidence that just a handful of genetic mutations give E. coli the capacity to withstand doses of radiation that would otherwise doom the microbe. The findings are important because they have implications for better understanding how organisms can resist radiation damage to cells and repair damaged DNA.

"What our work shows is that the repair systems can adapt and those adaptations contribute a lot to radiation resistance," says University of Wisconsin-Madison biochemistry Professor Michael Cox, the senior author of the eLife report.

In previous work, Cox and his group, working with John R. Battista, a professor of biological sciences at Louisiana State University, showed that E. coli could evolve to resist ionizing radiation by exposing cultures of the bacterium to the highly radioactive isotope cobalt-60. "We blasted the cultures until 99 percent of the bacteria were dead. Then we'd grow up the survivors and blast them again. We did that twenty times," explains Cox.

The result were E. coli capable of enduring as much as four orders of magnitude more ionizing radiation, making them similar to Deinococcus radiodurans, a desert-dwelling bacterium found in the 1950s to be remarkably resistant to radiation. That bacterium is capable of surviving more than one thousand times the radiation dose that would kill a human. "Deinococcus evolved mainly to survive desiccation, not radiation," Cox says, "so when conditions are right, it can repair damage very quickly and start growing again."

Understanding the molecular machinery that allows some organisms to survive what would otherwise be lethal doses of radiation is important because the same bacterial machinery that repairs DNA and protects cells in microbes exists in humans and other organisms. Although turning the new findings into application is in the distant future, the results could ultimately contribute designer microbes capable of helping clean radioactive waste sites or making probiotics that could aid patients undergoing radiation therapy for some cancers.

The new study demonstrates that organisms can actively repair genetic damage from ionizing radiation. Prior to the new work, scientists thought the ability of cells to resist radiation stemmed primarily from their ability to detoxify the reactive oxygen molecules created by radiation within cells.

That passive detoxification approach, notes Cox, is most likely working in tandem with active mechanisms such as the mutations found by the Wisconsin group as well as other, yet-to-be-discovered mechanisms.

"This extreme resistance we're looking at is a complicated phenotype," says Cox. "There are likely additional mechanisms buried in this data and we're working to pull those out."


'/>"/>

Contact: Michael Cox
mcox@wisc.edu
608-262-1181
University of Wisconsin-Madison
Source:Eurekalert

Related medicine news :

1. Let there be tissue-penetrating light: Scientists develop new nanoscale method to fight cancer
2. Scientists discover new protein involved in lung cancer
3. Scientists explore promising new option for first line of attack in lymphoma
4. Tel Aviv University scientists honored for proposals in melanoma research
5. Scientists call for screening mammography every 2 years for most women
6. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
7. Scientists develop powerful new animal model for metastatic prostate cancer
8. NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer
9. Scripps Florida scientists find regulator of amyloid plaque buildup in Alzheimers disease
10. NCCS scientists discover gene regulation is dependent on protein ANP32E
11. Scientists make your stomach turn bright green if you have an ulcer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... Back Pain Centers of America (BPC), which ... physician in their area, announces the launch of a new and proprietary customer relationship ... looking for reputable physicians to help them with back or neck pain and helps ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare ... Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , ... medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... -- Companion animal vaccines are ... such as canine, avian and feline. ... as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, ... Vaccines. Attenuated live vaccines are derived from disease-causing ... been weakend under laboratory conditions. Conjugate vaccines are ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
Breaking Medicine Technology: